asi-02
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Nov 5, 2025 (NCT06938347)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 3 Sponsor(trial)
Mechanism of action
- UnclearContrast agent
Unclear contrast agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06938347 | Phase 3 | Nov 5, 2025 | Agitated Solutions, Inc., Bright Research Partners, Northwestern University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Agitated Solutions, Inc. | For profit | 1 | 1 | 1 | 2025 |
| Bright Research Partners | For profit | 1 | 0 | 1 | 2025 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 2025 |
3 organizations
Page 1 / 1